Presbyopia Treatment Market is segmented By Pharmacological Therapies (Parasympathomimetics, Cholinomimetics), By Optical Corrections (Eyeglasses, Contact Lenses), By Geo ....
Market Size in USD
CAGR5.4%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.4% |
Market Concentration | Medium |
Major Players | AbbVie, Eyenovia, Orasis Pharmaceuticals, Novartis, Visus Therapeutics |
The presbyopia treatment market is estimated to be valued at USD 19.1 Bn in 2024 and is expected to reach USD 26.4 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. With growing geriatric population worldwide experiencing presbyopia, the demand for treatment options is rising steadily.
The market is witnessing positive trends with advancements in treatment technologies. Presbyopia-correcting intraocular lenses have gained significant popularity as they not only address the near vision difficulties associated with presbyopia but also cataract formation. Additionally, the introduction of novel drug therapies and less invasive treatment options such as scleral expansion rings and contact lenses are expected to further drive the market during the forecast period.